Lago SYA, Labrada TDÁ, Breijo PA, Lago SD, Sosa GD

Language: Spanish
References: 11
Page:
PDF size: 213.84 Kb.

ABSTRACT

Introduction: cardiovascular diseases are the main cause of morbidity and mortality, despite improvements in clinical results and the introduction of new drugs.
Objective: to evaluate the influence of risk factors in the development of cardiovascular diseases in adults aged 18 years or older.
Method: a retrospective study of cases and controls was carried out in patients diagnosed with cardiovascular disease who attend the internal medicine service of the General University Hospital "Carlos Manuel de Céspedes," Bayamo, Granma, from January 5, 2017 to December 31, 2018. Within the risk factors, age, gender, comorbidity and biological markers were taken into account.
Results: among the qualitative variables, smoking was the most important factor (OR: 3.60; CI: 1.664-7.787; p: 0.001) while among the quantitative variables it was systolic hypertension (OR: 11.50; CI: 1457-90896, p: 0.004). Multivariate analysis showed that systolic hypertension was the most relevant independent risk factor (OR: 11.52; 95% CI: 3.077-43.168; p: 0.000) followed by having a history of diabetes mellitus (OR: 5.91 ;95% CI: 1674-20910).
Conclusions: systolic hypertension stands out as the most important independent risk factor, followed by suffering from diabetes mellitus and being 60 years of age or older.

REFERENCES

1. Benavides Bautista PA, Sánchez Villacis L, Álvarez P, Manzano V, Zambrano D. Diagnóstico, imagenología y accidente cerebrovascular. Enferm Inv (Ambato) 2018; 3(Sup. 1): 77-83.

2. García Alfonso C, Martínez Reyes A, García V, Ricaurte Fajardo A, Torres I, Coral J. Actualización en diagnóstico y tratamiento del ataque cerebrovascular isquémico agudo. Univ. Med. 2019; 60(3): 1-17.

3. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica. Rev Esp Cardiol 2016; 69(10):939.e1-e87.

4. Álvarez Aliaga A, González Aguilera JC, Maceo Gómez LR. Factors associated to hypertensive heart disease development: a prospective cohort study in Bayamo, Cuba. Medwave 2016; 16(6): e6492.

5. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Health care Professionals Fromthe American Heart Association/American Stroke Association. Stroke 2018;49(3): e46-e49.

6. García Jurado P, Roldán Romero E, Pérez Montilla ME, Valverde Moyano R, Bravo Rey IM, Delgado Acosta F, et al. Incidencia, pronóstico y predicción de la transformación hemorrágica tras el tratamiento revascularizador del ictus. Neurología 2021; 36(8): 589-96.

7. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb DC, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71(6): e13-e115.

8. Gállego Culleré J. Protocolo de tratamiento del ictus isquémico en fase aguda. Medicine 2019; 12(70): 4130-4137.

9. Sequeira Quesada CM, Villegas Reyes JD. Actualidad en el uso de la terapia dual en antiagregación plaquetaria con aspirina y clopidogrel en el manejo agudo de enfermedad cerebrovascular. Revista Clínica de la Escuela de Medicina UCR-HRjD 2017; 7(3): 11-21.

10. Izcovich A, Caruso D, Tisi M, Bottaro F, Pollán J, Saavedra E, et al. Doble terapia antiagregante en pacientes con accidente cerebrovascular isquémico agudo. Recomendaciones del grupo CIERTO. Medicina (Buenos Aires) 2019; 79(4): 315-321.

11. Organización Panamericana de la Salud. Perfil de Salud-Costa Rica. OPS. [Internet]. 2007 [citado 8/12/2021]. Disponible en: https://www3.paho.org/disasters/index.php?option=com_content&view=article&id=566:perfil-de-salud-costa-rica&Itemid=775&lang=es.